Director/PDMR Shareholding
Summary by AI BETAClose X
|
Ninety One Limited
|
Ninety One plc LEI: 549300G0TJCT3K15ZG14 |
Notification of transactions by relevant Directors, Persons Discharging Managerial Responsibilities and persons closely associated with them, prescribed officers, company secretaries and associates.
As part of the dual listed company structure, Ninety One plc and Ninety One Limited (together "Ninety One") notify both the London and Johannesburg Stock Exchanges of those interests (and changes to those interests) of (i) directors of both entities and the respective company secretaries and such persons' respective associates and persons closely associated with them, (ii) prescribed officers and persons discharging managerial responsibilities ("PDMRs") and such persons' respective associates and persons closely associated with them, and (iii) in certain instances the directors and company secretaries of major subsidiaries of Ninety One and such persons' respective associates, in the securities of Ninety One plc and Ninety One Limited which are required to be disclosed under Article 19(1) of the Market Abuse Exit Regulations 2019 ("UK MAR"), the Listing Rules, and the Disclosure Guidance and Transparency Rules of the FCA and/or the JSE Listings Requirements. Clearance was obtained for the below dealing in securities.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated / associate
|
|||||||||
|
a)
|
Legal person
|
Forty Two Point Two |
||||||||
|
2
|
Reason for the notification
|
|||||||||
|
a)
|
Position/status
|
In terms of UK MAR, the Listing Rules, and the Disclosure Guidance and Transparency Rules of the FCA, this notification concerns a person closely associated with Hendrik du Toit and Kim McFarland, each of whom is a Director of Ninety One plc (i.e. a PDMR). In terms of the JSE Listings Requirements, Forty Two Point Two is wholly owned by the Marathon Trust and the undermentioned persons (who are directors of Ninety One plc, Ninety One Limited and/or major subsidiaries of Ninety One) are beneficiaries of the Marathon Trust. Forty Two Point Two is an associate of these persons for the purpose of the JSE Listings Requirements:- · Hendrik du Toit - Director of Ninety One plc and Ninety One Limited · Kim McFarland - Director of Ninety One plc and Ninety One Limited · Johan Schreuder - Director of Ninety One Assurance Limited · Adam Fletcher - Director of Ninety One Guernsey Limited · Malcolm Gray - Director of Ninety One Assurance Limited |
||||||||
|
b)
|
Initial notification /Amendment
|
Initial notification
|
||||||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
|
a)
|
Name
|
Ninety One plc |
||||||||
|
b)
|
LEI
|
549300G0TJCT3K15ZG14 |
||||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of GBP0.0001 each
GB00BJHPLV88 |
||||||||
|
b)
|
Nature of the transaction |
Acquisition of shares |
||||||||
|
c)
|
Price(s) and volume(s)
|
a)
b)
|
||||||||
|
d)
|
Date of the transaction |
a) 18 November 2025 b) 19 November 2025
|
||||||||
|
e)
|
Place of the transaction |
London Stock Exchange |
||||||||
Date of release: 20 November 2025
JSE Sponsor: J.P. Morgan Equities South Africa (Pty) Ltd
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 19 minutes ago JPMorgan Emerging Markets Growth & Income plc
- 21 minutes ago National Grid
- 57 minutes ago City of London Investment Group
- 1 hour ago BioPharma Credit
- 1 hour ago BioPharma Credit